Brief: Emergent BioSolutions Q1 Revenue USD 222.2 Million

Emergent BioSolutions

07/05/2025 21:05

May 07 (Reuters) - Emergent BioSolutions Q1 adjusted EBITDA USD 77.6 million.

Q1 adjusted gross margin 58%

Q1 net income USD 68 million

Q1 adjusted net income USD 40.7 million

Q1 gross margin 50%